Neuroton (Citicoline Sodium)

Citicoline Sodium provides choline and cytidine, which are essential precursors for phosphatidylcholine synthesis, a major phospholipid of neuronal membranes. This promotes membrane repair, increases acetylcholine production, and supports RNA synthesis, together delivering neuroprotective and cognitive‑supportive effects.

The appropriate dose of Neuroton is determined by the prescribing healthcare professional based on the patient’s condition, severity, and route of administration. Dosage regimens are individualized and should follow the prescriber’s instructions and local regulatory guidelines.

Safety data for Citicoline Sodium during pregnancy and lactation are limited. It is generally advised to avoid use unless the potential benefit justifies the potential risk to the fetus or infant. Clinicians should discuss individual circumstances with the patient.

To order Neuroton, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and necessary import documentation.

Neuroton (Citicoline Sodium) belongs to the cholinergic/nootropic class, whereas alternatives such as piracetam act primarily as cerebral metabolic enhancers. Citicoline directly supplies membrane‑building precursors and boosts acetylcholine, offering both neuroprotective and membrane‑repair benefits that differ from the purely metabolic effects of piracetam.

Neuroton should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations. Follow standard aseptic handling procedures when preparing for intramuscular or intravenous administration.

Neuroton is supplied as an injectable solution for intramuscular or intravenous injection. Administration is performed by a qualified healthcare professional following aseptic technique, with the route and infusion rate selected according to the clinical indication and prescribing information.

Serious risks, although rare, include allergic reactions such as rash, angioedema, significant hypotension, seizures, and abnormal liver‑function test results. Patients should be monitored for any signs of these events, and therapy should be discontinued if a serious adverse reaction occurs.

Neuroton should be avoided in individuals with known hypersensitivity to Citicoline Sodium or any excipients in the formulation. Caution is also advised for patients with severe renal impairment, uncontrolled hypertension, or those taking medications that may interact significantly, such as MAO inhibitors, anticholinergics, or anticoagulants, unless closely supervised.